Literature DB >> 30203603

Impact of Pharmacists on Access to Vaccine Providers: A Geospatial Analysis.

Parth D Shah1,2, Justin G Trogdon2,3, Shelley D Golden2,3, Carol E Golin1,2, Macary Weck Marciniak4, Noel T Brewer2,3.   

Abstract

Policy Points: Policymakers in the United States should consider expanding pharmacy practice laws to allow pharmacists to vaccinate adolescents as a way to improve geographic access to adolescent vaccines, particularly for human papillomavirus (HPV) vaccine, which has low uptake. Our state-level analysis showed that pharmacists are more geographically dispersed than primary care physicians in the US state of Texas. Including pharmacists among available adolescent vaccine providers would improve the geographic distribution of vaccine providers, especially in areas with an inadequate number of primary care physicians. CONTEXT: The largest disparities in human papillomavirus (HPV) vaccination in the United States are due to geography. One potential way of addressing these disparities is by improving geographic access to HPV vaccination. Two federal panels have recommended including community pharmacists as HPV vaccine providers as a strategy to improve opportunities for HPV vaccination for adolescents. We sought to evaluate whether community pharmacists can improve the number of vaccine providers in areas with primary care physician shortages in the US state of Texas.
METHODS: We gathered publicly available physician and pharmacist 2016 workforce data from the Texas Medical Board and Board of Pharmacy. We conducted geospatial analysis of census tracts to analyze the distribution of physicians and pharmacists and how pharmacists change vaccine provider coverage across the state.
FINDINGS: Census tracts with high numbers of physicians per capita tended to be located near one another, in 5 of 5 analyses of Moran's I (median = .04). In contrast, pharmacist rates were not spatially dependent on census tract in any of our analyses. If pharmacists were added to primary care physicians as vaccine providers, 35% of urban census tracts that previously had inadequate coverage would be adequately covered, while 18% of inadequately covered rural census tracts would become adequately covered. Overall, when pharmacists were included with primary care physicians as vaccine providers, vaccine providers per capita increased in 2,413 of the 4,508 urban census tracts (54%), while the rate increased in 223 of 746 rural census tracts (30%).
CONCLUSIONS: Pharmacists are more geographically dispersed across census tracts than primary care physicians. As a result, adding pharmacists to the workforce would increase the availability of vaccine providers in areas with inadequate primary care provider coverage.
© 2018 Milbank Memorial Fund.

Entities:  

Keywords:  HPV vaccine; access to health care; geographic factors; pharmacists

Mesh:

Substances:

Year:  2018        PMID: 30203603      PMCID: PMC6131320          DOI: 10.1111/1468-0009.12342

Source DB:  PubMed          Journal:  Milbank Q        ISSN: 0887-378X            Impact factor:   4.911


  41 in total

1.  Preventive care for adolescents: few get visits and fewer get services.

Authors:  Charles E Irwin; Sally H Adams; M Jane Park; Paul W Newacheck
Journal:  Pediatrics       Date:  2009-04       Impact factor: 7.124

2.  Geographic maldistribution of primary care for children.

Authors:  Scott A Shipman; Jia Lan; Chiang-Hua Chang; David C Goodman
Journal:  Pediatrics       Date:  2010-12-20       Impact factor: 7.124

3.  Can School-Located Vaccination Have a Major Impact on Human Papillomavirus Vaccination Rates in the United States?

Authors:  Allison Kempe; Mandy A Allison; Matthew F Daley
Journal:  Acad Pediatr       Date:  2018-03       Impact factor: 3.107

4.  National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines.

Authors:  Cynthia M Rand; Laura P Shone; Christina Albertin; Peggy Auinger; Jonathan D Klein; Peter G Szilagyi
Journal:  Arch Pediatr Adolesc Med       Date:  2007-03

5.  Geospatial patterns in human papillomavirus vaccination uptake: evidence from uninsured and publicly insured children in North Carolina.

Authors:  Justin G Trogdon; Thomas Ahn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01-09       Impact factor: 4.254

Review 6.  Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists.

Authors:  Jennifer McIntosh; Deborah A Sturpe; Niharika Khanna
Journal:  J Am Pharm Assoc (2003)       Date:  2008 Jan-Feb

7.  HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US.

Authors:  Guodong Liu; Lan Kong; Ping Du
Journal:  Papillomavirus Res       Date:  2016-12

8.  Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 - United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-07-26       Impact factor: 17.586

9.  Designing financial-incentive programmes for return of medical service in underserved areas: seven management functions.

Authors:  Till Bärnighausen; David E Bloom
Journal:  Hum Resour Health       Date:  2009-06-26

10.  National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years--United States, 2014.

Authors:  Sarah Reagan-Steiner; David Yankey; Jenny Jeyarajah; Laurie D Elam-Evans; James A Singleton; C Robinette Curtis; Jessica MacNeil; Lauri E Markowitz; Shannon Stokley
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-31       Impact factor: 17.586

View more
  6 in total

1.  HPV Vaccine Coverage among Adolescent Males in Ohio: Results of a Longitudinal Study.

Authors:  Andreas A Teferra; Brittney Keller-Hamilton; Megan E Roberts; Paul L Reiter
Journal:  Ohio J Public Health       Date:  2019-12

2.  Supporting the pandemic response and timely access to COVID-19 vaccines: a case for stronger priority setting and health system governance in Nigeria.

Authors:  Otuto Amarauche Chukwu; Lydia Kapiriri; Beverley Essue
Journal:  Int J Pharm Pract       Date:  2022-06-25

3.  Disparity in Access to Oncology Precision Care: A Geospatial Analysis of Driving Distances to Genetic Counselors in the U.S.

Authors:  Mathias M J Bellaiche; Winnie Fan; Harold John Walbert; Egan H McClave; Bradley L Goodnight; Fred H Sieling; Rebekah A Moore; Weilin Meng; Christopher M Black
Journal:  Front Oncol       Date:  2021-06-16       Impact factor: 6.244

4.  Enrolling a rural community pharmacy as a Vaccines for Children provider to increase HPV vaccination: a feasibility study.

Authors:  Casey L Daniel; Frances Lawson; Macy Vickers; Chelsea Green; Anna Wright; Tamera Coyne-Beasley; Hee Y Lee; Stacie Turberville
Journal:  BMC Public Health       Date:  2021-06-29       Impact factor: 3.295

5.  Rural-Urban Disparities in Access to Medicaid-Contracted Pharmacies in Washington State, 2017.

Authors:  Janessa M Graves; Demetrius A Abshire; Megan Undeberg; Laura Forman; Solmaz Amiri
Journal:  Prev Chronic Dis       Date:  2020-08-20       Impact factor: 2.830

6.  Strategies for Disseminating and Implementing COVID-19 Vaccines in Rural Areas.

Authors:  Beth Prusaczyk
Journal:  Open Forum Infect Dis       Date:  2021-04-02       Impact factor: 3.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.